Distinguished Faculty:

Geoffrey M. Coan is a Partner in the Boston office of Wilson Elser Moskowitz Edelman & Dicker LLP. He has more than 15 years of litigation and trial experience in mass and complex tort litigation, including the areas of product liability, medical device, pharmaceutical, toxic tort, environmental and professional liability. Mr. Coan serves as national counsel to several pharmaceutical and medical device companies, coordinating the defense of product liability and mass tort litigation.

Mr. Coan serves as national counsel for a medical device company involved in mass tort litigation arising out of the use of a pain pump to deliver medication to the shoulder following arthroscopic surgery. He is also coordinating counsel for a medical device manufacturer in litigation arising out of a recall of a surgically implanted spinal fixation device.

Mr. Coan was named the Medmarc Insurance Group’s Attorney of the Year for 2008. He was also named to the Medmarc Insurance Group’s Honor Roll in 2006 and 2007, in recognition of his service to clients. Additionally, Mr. Coan was listed in the 2005 issue of Boston magazine as a “Massachusetts Rising Star.” A defense verdict he obtained in a wrongful death case was chosen as one of the 10 “Biggest Defense Wins of 2004” by Massachusetts Lawyers Weekly.

Megan Wynne is Vice President of Legal Affairs for I-Flow Corporation. I-Flow is a medical device company that designs, develops, manufactures and markets technically advanced ambulatory drug delivery systems which are focused in three primary market segments: Regional Anesthesia, IV Infusion Therapy and Oncology Infusion Services. Megan manages I-Flow’s litigation and provides advice on a variety of corporate matters. 

Prior to joining I-Flow, Ms. Wynne was a partner at Morris Polich & Purdy LLP in Los Angeles and chair of the firm’s Products Liability practice group. Her fifteen years of experience in private practice included products liability, environmental and toxic tort litigation and business law. Ms. Wynne has successfully tried jury and bench trials and has extensive experience representing manufacturers of medical devices, chemicals and pharmaceutical products, as well as distributors of various herbal supplements. She has served as national counsel for the manufacturer of a schedule II controlled substance used in prescription pain medication and national counsel for the manufacturer of a contact lens solution.  

Ms. Wynne received her B.A. from Johns Hopkins University and her J.D. from Boston College Law School. 

Cynthia Khin is the Chief Claims Officer of Insurance Operations, for Medmarc Insurance Group. In this capacity, she is responsible for medical technology and life sciences product liability claims investigation and settlement oversight, defense counsel selection, litigation management, trial preparation/supervision, claim reserve audits and assessments.

Ms. Khin holds the Chartered Property and Casualty Underwriter (CPCU) designations from the American Institutes for CPCU, Associate in Claims, Associate in Risk Management and certificates in Claims Law from the American Education Institute, and designations in Supervisory Management and General Insurance from the Insurance Institute of America. Ms. Khin has taught insurance classes in the Washington D.C. area. She has spoken on claims and litigation management topics before a variety of audiences, including the annual conference of Medical Device & Diagnostic Industry magazine, the International Risk Management Institute, the National Home Health Care Conference, International Business Consultants and numerous Medmarc risk management seminars. Her co-authored article, "We Love Settlements!" appeared in "For the Defense," the monthly publication of the Defense Research Institute.

Prior to joining Medmarc Insurance Group in 1989, Ms. Khin was with a leading casualty insurer, GEICO, in its home office where, for eight years, she assisted the company in shouldering litigation, management and training responsibilities.

David Cassak is a Managing Director of Elsevier Business Intelligence (EBI), A Reed Elsevier Company. He has been involved with the health care industry for more than 30 years and writes extensively on the medical device industry for Windhover’s IN VIVO and Start-Up. Mr. Cassak is alsoa frequent speaker before various companies and industry trade groups.

Prior to joining Elseiver, Mr. Cassak worked for nearly 20 years at Windhover Information Inc., a company he founded with partner Roger Longman, which spun out the publications business of The Wilkerson Group, a leading management consulting firm at the time. Long known for publishing IN VIVO, widely recognized as the premier provider of business intelligence in the health care industry, Windhover launched a number of other publications, including Start-Up: Emerging Medical Venture™, and The RPM Report: Regulation • Policy • Market Access™. In 2004, Windhover acquired Medtech Insight Inc., and now publishes the Medtech Insight: Medical Technology Market Intelligence™ newsletter. In addition, Windhover also created the Strategic Intelligence Systems (SIS), a web-based suite of databases, featuring the most comprehensive and detailed source of industry alliances, acquisitions and financings. SIS is unique among databases in providing expert commentary and analysis along with data.

Windhover/EBI also produces numerous conferences, including the Investment in Innovation (In3) medical-device-partnering conferences around the world, as well as such pharma-focused conferences as the Pharmaceutical Strategic Alliances, Euro-Biotech and BIO-Windhover meetings. It also offers a wide range of market research reports under its Medtech Insight imprint. In 2008, Windhover was acquired by Elsevier, which formed Elsevier Business Intelligence, combining the products of Windhover and FDC Reports, publishers of The Gray Sheet and The Pink Sheet, among other leading industry newsletters.